SEP 02, 2019 12:47 PM PDT

Drug Reduces Heart Attacks in Diabetic Patients

WRITTEN BY: Nouran Amin

Recent results from a clinical trial that evaluated the addition of a drug called ‘ticagrelor’ to aspirin were shown to improve clinical outcomes for patients with stable coronary artery disease and diabetes mellitus. These patients in the study had no history of heart attack or stroke.

Findings from the clinical trial known as ‘The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study (THEMIS), explained how the usage of ticagrelor with aspirin formed a dual-antiplatelet therapy that has reduced the risk of cardiovascular death, heart attack, and stroke. However, the study did show that patients on the dual therapy also experienced a greater risk of a major bleed and intracranial hemorrhage, particularly through an increased number of non-procedural subdural bleeds, in comparison to those who were on the placebo.

"With prolonged dual-antiplatelet therapy, we need to be thoughtful in considering which patients are most suited to taking the regimen -- that is, those at high ischemic risk and low bleeding risk," said THEMIS co-chair Deepak L. Bhatt, MD, MPH, executive director of Interventional Cardiovascular Programs at the Brigham and professor of medicine at Harvard Medical School. "Our findings show that the greatest benefit occurred in those patients with diabetes and stable coronary artery disease with a history of prior stenting for whom ticagrelor, when added to aspirin, reduced important cardiovascular events, such as heart attacks, strokes and amputations."

THEMIS is the largest clinical trial study involving diabetic patients to date with more than 19,000 participants who have stable coronary artery disease and diabetes that were randomly selected to receive either ticagrelor plus aspirin (the dual antiplatelet therapy) or a placebo plus aspirin. These patients were studied over the course of three years

"The THEMIS population is a critically important one in which to understand the potential benefits of taking ticagrelor in addition to aspirin. As the number of people with diabetes continues to rise globally, we need to evaluate ways of improving long-term outcomes and preventing cardiovascular and ischemic events,” says THEMIS co-chair Philippe Gabriel Steg, MD, Chief of Cardiology at Hôpital Bichat, Greater Paris University Hospitals.

Learn more about the heart disease-diabetes connection:

 

 

"Our results indicate that among those with diabetes and stable coronary artery disease, we should focus on ticagrelor for patients with a history of prior stenting. This is an easily identifiable, logical sub-group," said Bhatt. "Studies currently support using long-term dual antiplatelet therapy for patients with the acute coronary syndrome who are at high ischemic risk but low bleeding risk. Our work suggests that a much broader population of patients with stable coronary artery disease and diabetes stand to benefit substantially."

Source: Science Daily

 

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 22, 2019
Drug Discovery & Development
NOV 22, 2019
Researchers Can Now Reverse Skin Cancer
Ten years ago, just 5% of people with advanced melanoma (skin cancer) lived more than five years after being diagnosed. Now however, researchers from the I...
NOV 22, 2019
Genetics & Genomics
NOV 22, 2019
Non-Invasive Gene Therapy Holds Promise for Treating Blindness
Researchers at John Hopkins Medicine have found a way to deliver sight-saving gene therapy to the retina. Having already shown success in treating rates, p...
NOV 22, 2019
Cannabis Sciences
NOV 22, 2019
CBD Extract for Cannabis Addiction
Some people believe the secret to curing a hangover is to drink more alcohol the morning after a night of binge drinking - “the hair of the dog that...
NOV 22, 2019
Health & Medicine
NOV 22, 2019
FDA Cautions Against Cannabis Use During Pregnancy
A recent article published by NPR addresses the rapidly growing number of females using cannabis during pregnancy. Those with tough pregnancy side effects ...
NOV 22, 2019
Drug Discovery & Development
NOV 22, 2019
How Fluorescent Probes Can Enhance Drug Delivery
Researchers at Cornell University are working on improving the trial-and-error process that is implicated in finding effective molecules for drug delivery....
NOV 22, 2019
Genetics & Genomics
NOV 22, 2019
New Way to Determine What Our Genes Do
Geneticists at the University of Virginia (UVA) School of Medicine have developed a new way to determine what our genes do. This will not only allow scient...
Loading Comments...